Accessibility Menu
Zentek logo

Zentek(TSXV) ZEN

Market CapCA$88.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+15%
5 Year-80%
1 Year-38%
1 Month-23%
CA$0.72
+2.86%
+0.02Today
Zentek last closing stock price
MetricPriceDate
Last closeCAD 0.722026-09-03
Zentek stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.49%CAD 0.772026-08-27
1 month-23.4%CAD 0.942026-08-04
3 month+2.86%CAD 0.702026-06-05
Year to date-19.1%CAD 0.892025-12-31
1 year-38.46%CAD 1.172025-09-03
3 year-61.29%CAD 1.862023-09-01
5 year-80.49%CAD 3.692021-09-03
Since inception+14.75%CAD 0.612010-12-23

Zentek Financials at a Glance

Market Cap

CA$88.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$108.25K

Net Income (TTM)

-CA$10.45M

EPS (TTM)

-CA$0.10

P/E Ratio

-7.25

Dividend

CA$0.00

Beta (Volatility)

0.12 (Low)

Price

CA$0.72

Volume

110,122

Open

CA$0.71

Previous Close

CA$0.72

Daily Range

CA$0.71 - CA$0.75

52-Week Range

CA$0.52 - CA$1.50

Estimated Earnings Date

Nov 12, 2026

ZEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zentek

Zentek Ltd. is a Canadian company specializing in the exploration and advancement of graphene and related nanomaterials. The firm is known for its innovative ZenGUARD brand, which features a graphene-based antimicrobial coating used in various applications, including surgical masks and HVAC filters.

Products and Services
  • Graphene-based antimicrobial coatings for personal protective equipment
  • Point-of-care diagnostics leveraging graphene compounds
  • Synthesis of graphene, graphene oxide, and quantum dots for diverse applications
Growth Outlook
  • Expansion into healthcare markets with innovative graphene applications
  • Increased demand for antimicrobial solutions post-pandemic
  • Strategic partnerships to enhance product development and market reach
Financial Highlights
  • Recent quarterly revenue of CAD 36,767, showing potential for growth
  • Cash and cash equivalents increased to CAD 16,596,696 in Q1 2026
  • Current ratio of 4.65 indicates strong liquidity position
Zentek Ltd. is positioned in the rapidly evolving field of nanotechnology, particularly graphene applications. The company's focus on antimicrobial solutions aligns with growing global health concerns, especially in the wake of the COVID-19 pandemic. With a solid cash position and strategic growth initiatives, Zentek is well-placed to capitalize on emerging opportunities in various sectors, including healthcare and environmental solutions. The company's innovative products and commitment to research and development may attract interest from investors looking for exposure to cutting-edge technology in the materials sector.
AI Generated • Aug 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

CEO

Mohammed Jiwan

Website

www.zentek.com

Headquarters

Guelph, ON N1E 6Z1, CA

ZEN Financials

Key Financial Metrics (TTM)

Gross Margin

-5018.33%

Operating Margin

-10055.02%

Net Income Margin

-9652.83%

Return on Equity

-70.73%

Return on Capital

-92.44%

Return on Assets

-33.86%

Earnings Yield

-13.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$88.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

126.62M

Volume

110.12K

Avg. Volume

207.36K

Financials (TTM)

Gross Profit

-CA$5.43M

Operating Income

-CA$10.88M

EBITDA

-CA$10.59M

Operating Cash Flow

-CA$5.07M

Capital Expenditure

-CA$499.65K

Free Cash Flow

-CA$5.57M

Cash & ST Invst.

CA$16.60M

Total Debt

CA$1.93M

Zentek Performance Analysis

Zentek annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 72,855-78.6%
20242024-03-31CAD 29,816-59.1%
20252025-03-31CAD 872,4952826.3%
20262026-03-31CAD 166,048-81.0%
Zentek sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-89.3%
Q32025-12-31952.2%
Q42026-03-31-43.7%
Q12026-06-30-100.0%
Zentek annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.15-57.9%
20242024-03-31CAD -0.12-19.7%
20252025-03-31CAD -0.10-16.2%
20262026-03-31CAD -0.09-5.4%
Zentek sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-53.8%
Q32025-12-31-16.5%
Q42026-03-31-40.3%
Q12026-06-3045.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$0.00

-100.0%

Gross Profit

-CA$1.22M

-4594.5%

Gross Margin

0.00%

N/A

Market Cap

CA$88.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$8.86M

N/A

Employees

10

N/A

Net Income

-CA$2.04M

-50.0%

EBITDA

-CA$2.06M

-76.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$16.60M

+474.5%

Total Debt

CA$1.93M

+2.7%

Accounts Receivable

CA$391.78K

-0.7%

Inventory

CA$393.49K

-55.9%

Long Term Debt

CA$1.81M

+6.6%

Short Term Debt

CA$115.17K

-35.2%

Return on Assets

-33.86%

N/A

Return on Invested Capital

-40.20%

N/A

Free Cash Flow

-CA$1.18M

+3.9%

Operating Cash Flow

-CA$1.18M

-0.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDNA.TOMedicenna Therapeutics Corp.
CA$0.47+2.17%
RX.VBioSyent Inc.
CA$15.88-0.75%
CRDL.TOCardiol Therapeutics Inc.
CA$2.98-1.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.77-0.01%
HPEHewlett Packard Enterprise
$54.44+0.05%
FFord Motor Company
$14.41+0.02%
SNAPSnap
$5.70+0.02%

Questions About ZEN

What is the current price of Zentek?

Zentek is trading at CA$0.72 per share.

What is the 52-week range for Zentek?

Over the past 52 weeks, Zentek has traded between CA$0.52 and CA$1.50.

How much debt does Zentek have?

As of the most recent reporting period, Zentek reported total debt of CA$1.93M.

How much cash does Zentek have on hand?

Zentek reported CA$16.60M in cash and cash equivalents in its most recent financial results.

What is Zentek’s dividend yield?

Zentek does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services